D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 56 Citations 11,883 106 World Ranking 2110 National Ranking 1037

Overview

What is she best known for?

The fields of study she is best known for:

  • Virus
  • Internal medicine
  • Disease

Ruth A. Karron spends much of her time researching Virology, Virus, Immunology, Vaccination and Respiratory Syncytial Virus Vaccines. Her Virology research is multidisciplinary, incorporating elements of Innate immune system, Recombinant virus and Microbiology. Her study looks at the relationship between Virus and topics such as Immunity, which overlap with Cytokine, Inflammation, Glycoprotein and Cellular immunity.

Her study looks at the intersection of Immunology and topics like Disease with Case-control study and Respiratory system. Her Respiratory Syncytial Virus Vaccines research integrates issues from Viral disease, Respiratory tract, Rsv vaccine and Viral shedding. Her Immunization research focuses on Live attenuated influenza vaccine and how it relates to Family medicine, Health care, Pandemic and Influenza A virus.

Her most cited work include:

  • Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. (967 citations)
  • Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine (521 citations)
  • Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. (379 citations)

What are the main themes of her work throughout her whole career to date?

Ruth A. Karron focuses on Virology, Immunology, Virus, Vaccination and Immunogenicity. Her work deals with themes such as Respiratory Syncytial Virus Vaccines and Antibody, which intersect with Virology. Her work in Immunology covers topics such as Respiratory tract which are related to areas like Disease.

The concepts of her Virus study are interwoven with issues in Immunoglobulin G and Respiratory system. Her Vaccination study combines topics in areas such as Hemagglutinin, Hemagglutination assay, Pandemic and Family medicine. Ruth A. Karron works mostly in the field of Immunogenicity, limiting it down to topics relating to Rotavirus and, in certain cases, Serotype, as a part of the same area of interest.

She most often published in these fields:

  • Virology (53.50%)
  • Immunology (45.22%)
  • Virus (42.68%)

What were the highlights of her more recent work (between 2017-2021)?

  • Virology (53.50%)
  • Virus (42.68%)
  • Vaccination (29.30%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Virology, Virus, Vaccination, Respiratory Syncytial Virus Vaccines and Immunogenicity. In her study, Active immunization is strongly linked to RSV Vaccines, which falls under the umbrella field of Virology. Her work on Neutralizing antibody as part of general Virus research is often related to Virus vaccine, thus linking different fields of science.

Her work on Live attenuated influenza vaccine as part of general Vaccination study is frequently linked to Advisory committee, therefore connecting diverse disciplines of science. Her research integrates issues of Global health, Titer, Burden of disease and Rsv vaccine in her study of Respiratory Syncytial Virus Vaccines. Her Immunogenicity study combines topics from a wide range of disciplines, such as Infectivity and Antibody titer.

Between 2017 and 2021, her most popular works were:

  • The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. (174 citations)
  • Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study (157 citations)
  • Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response (35 citations)

In her most recent research, the most cited papers focused on:

  • Virus
  • Internal medicine
  • Disease

Ruth A. Karron mainly focuses on Virus, Virology, Virus vaccine, Public health and Clinical trial. Her Virus study incorporates themes from Respiratory Syncytial Virus Vaccines and Reactogenicity, Immunogenicity. Her research in Reactogenicity intersects with topics in Titer, Neutralizing antibody, Respiratory syncytial virus and Vaccination.

Her research related to Infectivity, Enterovirus and Rhinovirus might be considered part of Virology. Her Public health research includes elements of Infectious disease and Zika virus. Her Clinical trial research is multidisciplinary, incorporating perspectives in Respiratory tract, Respiratory system, Virus diseases and Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Lisa A. Grohskopf;Leslie Z. Sokolow;Leslie Z. Sokolow;Sonja J. Olsen;Joseph S. Bresee.
Morbidity and Mortality Weekly Report (2015)

1594 Citations

Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine

Clayton D. Harro;Yuk Ying Susana Pang;Richard B.S. Roden;Allan Hildesheim.
Journal of the National Cancer Institute (2001)

758 Citations

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

Ruth A. Karron;Deborah A. Buonagurio;Alice F. Georgiu;Stephen S. Whitehead.
Proceedings of the National Academy of Sciences of the United States of America (1997)

577 Citations

Prevention and Control of Seasonal Influenza with Vaccines.

Lisa A. Grohskopf;Leslie Z. Sokolow;Karen R. Broder;Sonja J. Olsen.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control (2016)

557 Citations

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn.
American Journal of Tropical Medicine and Hygiene (2001)

382 Citations

A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease

Fernando P. Polack;Michael N. Teng;Peter L.Collins;Gregory A. Prince.
Journal of Experimental Medicine (2002)

379 Citations

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson.
The Journal of Infectious Diseases (2000)

345 Citations

Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants

Ruth A. Karron;Peter F. Wright;Robert B. Belshe;Bhagvanji Thumar.
The Journal of Infectious Diseases (2005)

324 Citations

Respiratory syncytial virus and metapneumovirus

Peter L. Collins;Ruth A Karron.
(2013)

282 Citations

Risk factors for severe respiratory syncytial virus infection among Alaska Native children

Lisa R. Bulkow;Rosalyn J. Singleton;Rosalyn J. Singleton;Ruth A. Karron;Lee H. Harrison.
Pediatrics (2002)

281 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ruth A. Karron

Peter L. Collins

Peter L. Collins

National Institutes of Health

Publications: 118

Brian R. Murphy

Brian R. Murphy

National Institutes of Health

Publications: 100

Ralph A. Tripp

Ralph A. Tripp

University of Georgia

Publications: 62

Stephen S. Whitehead

Stephen S. Whitehead

National Institutes of Health

Publications: 62

Kanta Subbarao

Kanta Subbarao

University of Melbourne

Publications: 60

Barney S. Graham

Barney S. Graham

National Institutes of Health

Publications: 51

Alicia M. Fry

Alicia M. Fry

Centers for Disease Control and Prevention

Publications: 50

Mark E. Peeples

Mark E. Peeples

The Ohio State University

Publications: 49

Janet A. Englund

Janet A. Englund

Seattle Children's Hospital

Publications: 48

Shabir A. Madhi

Shabir A. Madhi

University of the Witwatersrand

Publications: 46

Eric A. F. Simões

Eric A. F. Simões

University of Colorado Denver

Publications: 44

John V. Williams

John V. Williams

University of Pittsburgh

Publications: 44

Anna P. Durbin

Anna P. Durbin

Johns Hopkins University

Publications: 39

Edward A. Belongia

Edward A. Belongia

Marshfield Clinic

Publications: 39

Peter J. M. Openshaw

Peter J. M. Openshaw

National Institutes of Health

Publications: 38

Pedro A. Piedra

Pedro A. Piedra

Baylor College of Medicine

Publications: 37

Something went wrong. Please try again later.